AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo

Jane Shearer, Patrick T. Fueger, Jeffrey N. Rottman, Deanna P. Bracy, Paul H. Martin, David H. Wasserman

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

AMP-activated protein kinase (AMPK) independently increases glucose and long-chain fatty acid (LCFA) utilization in isolated cardiac muscle preparations. Recent studies indicate this may be due to AMPK-induced phosphorylation and activation of nitric oxide synthase (NOS). Given this, the aim of the present study was to assess the effects of AMPK stimulation by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR; 10 mg·kg-1·min-) on glucose and LCFA utilization in cardiac muscle and to determine the NOS dependence of any observed effects. Catheters were chronically implanted in a carotid artery and jugular vein of Sprague-Dawley rats. After 4 days of recovery, conscious, unrestrained rats were given either water or water containing 1 mg/ml nitro-L-arginine methyl ester (L-NAME) for 2.5 days. After an overnight fast, rats underwent one of four protocols: saline, AICAR, AICAR + L-NAME, or AICAR + Intralipid (20%, 0.02 ml·kg-1·min-1). Glucose was clamped at ∼6.5 mM in all groups, and an intravenous bolus of 2-deoxy-[3H]glucose and [125I]-15-(p-iodophenyl)-3-R,S- methylpentadecanoic acid was administered to obtain indexes of glucose and LCFA uptake and clearance. Despite AMPK activation, as evidenced by acetyl-CoA carboxylase (Ser221) and AMPK phosphorylation (Thr172), AICAR increased cardiac LCFA but not glucose clearance. L-NAME + AICAR established that this effect was not due to NOS activation, and AICAR + Intralipid showed that increased cardiac LCFA clearance was not LCFA-concentration dependent. These results demonstrate that, in vivo, AMPK stimulation increases LCFA but not glucose clearance by a NOS-independent mechanism.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume287
Issue number5 50-5
DOIs
StatePublished - Nov 2004
Externally publishedYes

Fingerprint

AMP-Activated Protein Kinases
Muscle
Myocardium
Fatty Acids
Glucose
Nitric Oxide Synthase
NG-Nitroarginine Methyl Ester
Rats
Phosphorylation
Chemical activation
Acetyl-CoA Carboxylase
Arginine
Water
Catheters
Jugular Veins
AICA ribonucleotide
Carotid Arteries
Sprague Dawley Rats
Esters
Recovery

Keywords

  • AMP-activated protein kinase
  • Carbohydrate
  • Heart
  • Interaction
  • Lipid
  • Long-chain fatty acid
  • Substrate

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Biochemistry

Cite this

AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo. / Shearer, Jane; Fueger, Patrick T.; Rottman, Jeffrey N.; Bracy, Deanna P.; Martin, Paul H.; Wasserman, David H.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 287, No. 5 50-5, 11.2004.

Research output: Contribution to journalArticle

Shearer, Jane ; Fueger, Patrick T. ; Rottman, Jeffrey N. ; Bracy, Deanna P. ; Martin, Paul H. ; Wasserman, David H. / AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo. In: American Journal of Physiology - Endocrinology and Metabolism. 2004 ; Vol. 287, No. 5 50-5.
@article{4fb9874b49c3453b881614855dd32a0a,
title = "AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo",
abstract = "AMP-activated protein kinase (AMPK) independently increases glucose and long-chain fatty acid (LCFA) utilization in isolated cardiac muscle preparations. Recent studies indicate this may be due to AMPK-induced phosphorylation and activation of nitric oxide synthase (NOS). Given this, the aim of the present study was to assess the effects of AMPK stimulation by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR; 10 mg·kg-1·min-) on glucose and LCFA utilization in cardiac muscle and to determine the NOS dependence of any observed effects. Catheters were chronically implanted in a carotid artery and jugular vein of Sprague-Dawley rats. After 4 days of recovery, conscious, unrestrained rats were given either water or water containing 1 mg/ml nitro-L-arginine methyl ester (L-NAME) for 2.5 days. After an overnight fast, rats underwent one of four protocols: saline, AICAR, AICAR + L-NAME, or AICAR + Intralipid (20{\%}, 0.02 ml·kg-1·min-1). Glucose was clamped at ∼6.5 mM in all groups, and an intravenous bolus of 2-deoxy-[3H]glucose and [125I]-15-(p-iodophenyl)-3-R,S- methylpentadecanoic acid was administered to obtain indexes of glucose and LCFA uptake and clearance. Despite AMPK activation, as evidenced by acetyl-CoA carboxylase (Ser221) and AMPK phosphorylation (Thr172), AICAR increased cardiac LCFA but not glucose clearance. L-NAME + AICAR established that this effect was not due to NOS activation, and AICAR + Intralipid showed that increased cardiac LCFA clearance was not LCFA-concentration dependent. These results demonstrate that, in vivo, AMPK stimulation increases LCFA but not glucose clearance by a NOS-independent mechanism.",
keywords = "AMP-activated protein kinase, Carbohydrate, Heart, Interaction, Lipid, Long-chain fatty acid, Substrate",
author = "Jane Shearer and Fueger, {Patrick T.} and Rottman, {Jeffrey N.} and Bracy, {Deanna P.} and Martin, {Paul H.} and Wasserman, {David H.}",
year = "2004",
month = "11",
doi = "10.1152/ajpendo.00125.2004",
language = "English (US)",
volume = "287",
journal = "American Journal of Physiology - Renal Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "5 50-5",

}

TY - JOUR

T1 - AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo

AU - Shearer, Jane

AU - Fueger, Patrick T.

AU - Rottman, Jeffrey N.

AU - Bracy, Deanna P.

AU - Martin, Paul H.

AU - Wasserman, David H.

PY - 2004/11

Y1 - 2004/11

N2 - AMP-activated protein kinase (AMPK) independently increases glucose and long-chain fatty acid (LCFA) utilization in isolated cardiac muscle preparations. Recent studies indicate this may be due to AMPK-induced phosphorylation and activation of nitric oxide synthase (NOS). Given this, the aim of the present study was to assess the effects of AMPK stimulation by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR; 10 mg·kg-1·min-) on glucose and LCFA utilization in cardiac muscle and to determine the NOS dependence of any observed effects. Catheters were chronically implanted in a carotid artery and jugular vein of Sprague-Dawley rats. After 4 days of recovery, conscious, unrestrained rats were given either water or water containing 1 mg/ml nitro-L-arginine methyl ester (L-NAME) for 2.5 days. After an overnight fast, rats underwent one of four protocols: saline, AICAR, AICAR + L-NAME, or AICAR + Intralipid (20%, 0.02 ml·kg-1·min-1). Glucose was clamped at ∼6.5 mM in all groups, and an intravenous bolus of 2-deoxy-[3H]glucose and [125I]-15-(p-iodophenyl)-3-R,S- methylpentadecanoic acid was administered to obtain indexes of glucose and LCFA uptake and clearance. Despite AMPK activation, as evidenced by acetyl-CoA carboxylase (Ser221) and AMPK phosphorylation (Thr172), AICAR increased cardiac LCFA but not glucose clearance. L-NAME + AICAR established that this effect was not due to NOS activation, and AICAR + Intralipid showed that increased cardiac LCFA clearance was not LCFA-concentration dependent. These results demonstrate that, in vivo, AMPK stimulation increases LCFA but not glucose clearance by a NOS-independent mechanism.

AB - AMP-activated protein kinase (AMPK) independently increases glucose and long-chain fatty acid (LCFA) utilization in isolated cardiac muscle preparations. Recent studies indicate this may be due to AMPK-induced phosphorylation and activation of nitric oxide synthase (NOS). Given this, the aim of the present study was to assess the effects of AMPK stimulation by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR; 10 mg·kg-1·min-) on glucose and LCFA utilization in cardiac muscle and to determine the NOS dependence of any observed effects. Catheters were chronically implanted in a carotid artery and jugular vein of Sprague-Dawley rats. After 4 days of recovery, conscious, unrestrained rats were given either water or water containing 1 mg/ml nitro-L-arginine methyl ester (L-NAME) for 2.5 days. After an overnight fast, rats underwent one of four protocols: saline, AICAR, AICAR + L-NAME, or AICAR + Intralipid (20%, 0.02 ml·kg-1·min-1). Glucose was clamped at ∼6.5 mM in all groups, and an intravenous bolus of 2-deoxy-[3H]glucose and [125I]-15-(p-iodophenyl)-3-R,S- methylpentadecanoic acid was administered to obtain indexes of glucose and LCFA uptake and clearance. Despite AMPK activation, as evidenced by acetyl-CoA carboxylase (Ser221) and AMPK phosphorylation (Thr172), AICAR increased cardiac LCFA but not glucose clearance. L-NAME + AICAR established that this effect was not due to NOS activation, and AICAR + Intralipid showed that increased cardiac LCFA clearance was not LCFA-concentration dependent. These results demonstrate that, in vivo, AMPK stimulation increases LCFA but not glucose clearance by a NOS-independent mechanism.

KW - AMP-activated protein kinase

KW - Carbohydrate

KW - Heart

KW - Interaction

KW - Lipid

KW - Long-chain fatty acid

KW - Substrate

UR - http://www.scopus.com/inward/record.url?scp=6044272946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=6044272946&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00125.2004

DO - 10.1152/ajpendo.00125.2004

M3 - Article

VL - 287

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 1931-857X

IS - 5 50-5

ER -